An autocrine function of nerve growth factor for cell cycle regulation of vascular endothelial cells

Biochemical and Biophysical Research Communications

Volumn 313, Issue 4, 2004, Pages 1009-1014

  Tanaka, Akane ^a   Wakita, Utako ^a   Kambe, Naotomo ^a   Iwasaki, Tadashi ^a   Matsuda, Hiroshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Autocrine and or paracrine mechanisms; p75NGFR; TrkA; Vascular endothelial cells

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; PROTEIN TYROSINE KINASE;

ANIMAL CELL; AORTA; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CELL CYCLE; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; VASCULAR ENDOTHELIUM;

EID: 0347359158     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.036     Document Type: Article

References (31)

1. Liuzzi A., Angeletti P.U., Levi-Montalcini R. Metabolic effects of a specific nerve growth factor (NGF) on sensory and sympathetic ganglia: enhancement of lipid biosynthesis. J. Neurochem. 12:1965;705-708.
2. Toschi G., Dore E., Angeletti P.U., Levi-Montalcini R., de Haen C. Characteristics of labeled RNA from spinal ganglia of chick embryo and the action of a specific growth factor (NGF). J. Neurochem. 13:1966;539-544.
3. Mobley W.C., Rutkowski J.L., Tennekoon G.I., Buchanan K., Johnston M.V. Choline acetyltransferase activity in stratum of neonatal rats increased by nerve growth factor. Science. 229:1985;284-287.
4. Barde Y.A. The nerve growth factor family. Prog. Growth Factor Res. 2:1990;237-248.
5. Conover J.C., Yancopoulos G.D. Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev. Neurosci. 8:1997;13-27.
6. Jorg M.W., Rainer M., Rainer S. Nerve growth factor binding site on TrkA mapped to a single 24-amino acid leucin-rich motif. J. Biol. Chem. 270:1995;28133-28138.
7. Rodringuez-Tebar A., Dechant G., Barde Y.A. Binding of brain-derived neurotrophic factor to the nerve growth factor receptor. Neuron. 4:1990;487-492.
8. Barker P.A., Murphy R.A. The nerve growth factor receptor: a multicomponent system that mediates the actions of the neurotrophin family of proteins. Mol. Cell. Biochem. 110:1992;1-15.
9. Chao M.V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 9:1992;583-593.
10. Kaplan D.R., Hempstead B.L., Martin-Zanca D., Chao M.V., Parada L.F. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science. 252:1991;554-558.
11. Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 350:1991;678-683.
12. Ransohoff R.M., Tredst C. Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis. J. Exp. Med. 191:2000;1625-1630.
13. Aloe L. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc. Res. Tech. 45:1999;285-291.
14. Patel T.D., Jackman A., Rice F.L., Kucera J., Snider W.D. Development of sensory neurons in the absence of NGF/TrkA signaling in vivo. Neuron. 25:2000;345-357.
15. Pincelli C., Marconi A. Autocrine nerve growth factor in human keratinocytes. J. Dermatol. Sci. 22:2000;71-79.
16. Lambiase A., Rama P., Bonini S., Caprioglio G., Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med. 338:1998;1174-1180.
17. Bernabei R., Landi F., Bonini S., Onder G., Lambiase A., Pola R., Aloe L. Effect of topical application of nerve-growth factor on pressure ulcers. Lancet. 354:1999;307.
18. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA. 86:1989;10059-10063.
19. Kannan Y., Ushio H., Koyama H., Okada M., Oikawa M., Yoshida T., Kaneko M., Matsuda H. 2.5S nerve growth factor enhances survival, phagocytosis, and superoxide production of murine neutrophils. Blood. 77:1991;1320-1325.
20. Susaki Y., Shimizu S., Katakura K., Watanabe N., Kawamoto K., Matsumoto M., Tsudzuki M., Furusaka T., Kitamura Y., Matsuda H. Functional properties of murine macrophages promoted by nerve growth factor. Blood. 88:1996;4630-4637.
21. Kawamoto K., Okada T., Kannan Y., Ushio H., Matsumoto M., Matsuda H. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood. 86:1995;4638-4644.
22. Sawada J., Itakura A., Tanaka A., Furusaka T., Matsuda H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood. 95:2000;2052-2058.
23. Matsuda H., Koyama H., Sato H., Sawada J., Itakura A., Tanaka A., Matsumoto M., Konno K., Ushio H., Matsuda K. Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J. Exp. Med. 187:1998;297-306.
24. Donovan M.J., Lin M.I., Wiegn P., Ringstedt T., Kraemer R., Hahn R., Wang S., Ibanez C.F., Rafii S., Hempstead B.L. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development. 127:2000;4531-4540.
25. Nakahashi T., Fujimura H., Alter C.A., Li J., Kambayashi J., Tandon N.N., Sun B. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 470:2000;113-117.
26. Calza L., Giardino L., Giuliani A., Aloe L., Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc. Natl. Acad. Sci. USA. 98:2001;4160-4165.
27. Raychaudhuri S.K., Raychaudhuri S.P., Weltman H., Farber E.M. Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal micronascular endothelial cells. Arch. Dermatol. Res. 293:2001;291-295.
28. Gibran N.S., Tamura R., Tsou R., Isik F.F. Human dermal microvascular endothelial cells produce nerve growth factor: implication for wound repair. Shock. 19:2003;127-130.
29. Mitsuhashi M., Tanaka A., Fujisawa C., Kawamoto K., Itakura A., Takaku M., Hironaka T., Sawada S., Matsuda H. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells. J. Immunol. 166:2001;617-623.
30. Tanaka A., Arai K., Kitamura Y., Matsuda H. Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation. Blood. 94:1999;2390-2395.
31. Lad S.P., Peterson D.A., Bradshaw R.A., Neet K.E. Individual and combined effects of TrkA and p75NTR nerve growth factor (NGF) receptors: a role for the high affinity receptor site. J. Biol. Chem. 278:2003;24808-24817.